Lysosomal TMEM9-LAMTOR4-controlled mTOR signaling integrity is required for mammary tumorigenesis

Shengzhe Zhang; Sung Ho Lee; Litong Nie; Yuanjian Huang; Gengyi Zou; Youn Sang Jung; Sohee Jun; Jie Zhang; Esther M. Lien; Junjie Chen; Jae Il Park

doi:10.1002/cac2.12382

Lysosomal TMEM9-LAMTOR4-controlled mTOR signaling integrity is required for mammary tumorigenesis

Shengzhe Zhang, Sung Ho Lee, Litong Nie, Yuanjian Huang, Gengyi Zou, Youn Sang Jung, Sohee Jun, Jie Zhang, Esther M. Lien, Junjie Chen, Jae Il Park

Experimental Radiation Oncology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	159-163
Number of pages	5
Journal	Cancer Communications
Volume	43
Issue number	1
DOIs	https://doi.org/10.1002/cac2.12382
State	Published - Jan 2023

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cac2.12382

Cite this

@article{7776a2af08d747a5a8d305e1d4ad833b,

title = "Lysosomal TMEM9-LAMTOR4-controlled mTOR signaling integrity is required for mammary tumorigenesis",

author = "Shengzhe Zhang and Lee, {Sung Ho} and Litong Nie and Yuanjian Huang and Gengyi Zou and Jung, {Youn Sang} and Sohee Jun and Jie Zhang and Lien, {Esther M.} and Junjie Chen and Park, {Jae Il}",

note = "Funding Information: We thank Pierre D. McCrea, Malgorzata Kloc, and Rachel Miller for the discussion and Ann Sutton (Research Medical Library, MD Anderson) for editing the manuscript. This work was supported by the Cancer Prevention and Research Institute of Texas (RP200315 to J.‐I.P.), the National Cancer Institute (CA193297 and CA256207 to J.‐I.P.), an Institutional Research Grant (MD Anderson to J.‐I.P.), a Specialized Program of Research Excellence (SPORE) grant in endometrial cancer (P50 CA83639 to J.‐I.P.), and Radiation Oncology Research Initiatives. The core facilities used (DNA sequencing, Genetically Engineered Mouse Facility, and FACS Facility) were supported by Cancer Center Support Grant (P30 CA016672) from the National Cancer Institute to MD Anderson. ",

year = "2023",

month = jan,

doi = "10.1002/cac2.12382",

language = "English (US)",

volume = "43",

pages = "159--163",

journal = "Cancer Communications",

issn = "1000-467X",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Lysosomal TMEM9-LAMTOR4-controlled mTOR signaling integrity is required for mammary tumorigenesis

AU - Zhang, Shengzhe

AU - Lee, Sung Ho

AU - Nie, Litong

AU - Huang, Yuanjian

AU - Zou, Gengyi

AU - Jung, Youn Sang

AU - Jun, Sohee

AU - Zhang, Jie

AU - Lien, Esther M.

AU - Chen, Junjie

AU - Park, Jae Il

N1 - Funding Information: We thank Pierre D. McCrea, Malgorzata Kloc, and Rachel Miller for the discussion and Ann Sutton (Research Medical Library, MD Anderson) for editing the manuscript. This work was supported by the Cancer Prevention and Research Institute of Texas (RP200315 to J.‐I.P.), the National Cancer Institute (CA193297 and CA256207 to J.‐I.P.), an Institutional Research Grant (MD Anderson to J.‐I.P.), a Specialized Program of Research Excellence (SPORE) grant in endometrial cancer (P50 CA83639 to J.‐I.P.), and Radiation Oncology Research Initiatives. The core facilities used (DNA sequencing, Genetically Engineered Mouse Facility, and FACS Facility) were supported by Cancer Center Support Grant (P30 CA016672) from the National Cancer Institute to MD Anderson.

PY - 2023/1

Y1 - 2023/1

UR - http://www.scopus.com/inward/record.url?scp=85141533385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85141533385&partnerID=8YFLogxK

U2 - 10.1002/cac2.12382

DO - 10.1002/cac2.12382

M3 - Letter

C2 - 36336962

AN - SCOPUS:85141533385

SN - 1000-467X

VL - 43

SP - 159

EP - 163

JO - Cancer Communications

JF - Cancer Communications

IS - 1

ER -

Lysosomal TMEM9-LAMTOR4-controlled mTOR signaling integrity is required for mammary tumorigenesis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this